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Objective: To identify the protein regulation profile of recombinant human bone morphogenetic protein-2
(rhBMP-2)-induced osteogenic differentiation in beagle bone marrow stem cells (BMSCs).
Methods: Beagle BMSCs were isolated and cultured with or without rhBMP-2. Two-dimensional gel electrophoresis
was used to determine the differences in protein expression in rhBMP-2-induced and non-induced BMSCs.
Real-time PCR and western blotting analyses were used to verify the expression patterns of selected proteins.
Results: After the induction, the osteogenic differentiation of beagle BMSCs was activated successfully. Nine and 11
proteins were found to be down- and up-regulated by rhBMP-2, respectively. The increase in Lim and SH3 domain
protein 1(LASP1) and the decrease in ferritin were verified by real-time PCR and western blotting analyses.
Conclusions: Among the 20 rhBMP-2-regulated factors, there is empirical evidence supporting the involvement of
LASP1 and ferritin in osteogenic differentiation. LASP1 plays an important role in the regulation of the activity of
the cytoskeleton, and ferritin is an important molecule in cellular iron homeostasis. Further studies focused on
these 20 proteins will help elucidate the molecular mechanism(s) through which rhBMP-2 induces osteogenic
differentiation of BMSCs.
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The repair of large segmental bone defects caused by
trauma or disease is a very difficult process in orthopedic
clinics. Sources of autologous bone grafts are limited
and allogeneic grafts may be rejected and might induce
infection. The effect of artificial bone products for this
purpose is still uncertain. Thus, the use of autologous
bone marrow stem cells (BMSCs) to build/repair bone
tissue and to treat bone defects has been proposed as a
new treatment option in recent years. BMSCs are a subset
of non-hematopoietic bone marrow stromal cells. They
are easy to obtain and culture, and can be amplified
in vitro and transformed to multi-line ages without
loss of genetic stability [1]. BMSCs have a multi-potent
differentiation potential in vitro under certain conditions.* Correspondence: hjj0610@163.com; hjj0610@163.com
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reproduction in any medium, provided the orBMSCs can differentiate into adipocytes, osteoblasts,
chondrocytes, and vascular smooth muscle, skeletal muscle,
heart, endothelial, nerve, and liver cells, among others [2].
Thus, BMSCs have become the most promising seed cells
for bone tissue engineering [3].
Bone morphogenetic proteins (BMPs) are bone growth
factors that are known to induce osteogenesis [3]. These
growth factors themselves are sufficient to induce bone
formation [3]. Under certain conditions, they can induce
undifferentiated mesenchymal cells to transform to bone
cells and promote the proliferation of bone cells [3].
BMPs are currently considered the most important
factor in osteogenesis [4,5]. The effect of recombinant
human BMP-2 (rhBMP-2) on osteogenic differentiation
of BMSCs is well-studied, and rhBMP-2 has already
been applied widely in animal experiments and clinical
applications [2]. In previous studies, we have also tested
the utility of tissue-engineered bone containing rhBMP-2
and BMSCs in repairing bone defects in rabbits [6,7].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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osteogenic differentiation are currently not known.
The source of BMSC specimens are mainly mice, rats,
and humans. Human BMSCs are in limited supply and it
is difficult to carry out studies with human BMSCs.
BMSCs from mice or rats are quite different from
human BMSCs in physiology. Beagle is considered an
ideal large animal model widely used in pre-clinical
toxicological experiments, basic medical research, radiation
sickness treatment, and experimental surgery. Therefore, in
this study, we established a model for BMSC primary cell
culture and rhBMP-2-induced osteogenic differentiation
using Beagle dogs. Proteomic analysis was used to identify
proteins regulated by rhBMP-2. The results provide an
improved understanding of the rhBMP-2-induced
osteogenic differentiation of BMSCs.
Material and methods
Culture and induction of differentiation of BMSCs
According to standard bone marrow puncture procedures,
5 to 10 mL of bone marrow was aspirated from the
posterior superior iliac spine of beagles. Heparin was
added to the bone marrows to block coagulation and then
the marrows were diluted with an equal volume of
phosphate-buffered saline (PBS). The diluted bone
marrows were layered onto lymphocyte separation
medium (Sigma-Aldrich) at a ratio of 2:1, followed by
centrifugation at 400 × g for 30 min. After centrifugation,
the white layer between the two layers generated after
centrifugation was collected and washed twice with
PBS. Cells were seeded in culture plates at a density
of 1 × 106 cells/well and cultured in Dulbecco’s modified
Eagle medium (DMEM) containing 10% fetal bovine serum,
100 U/mL penicillin, and 100 U/mL streptomycin at 37°C
in an atmosphere of 5% CO2 and 95% humidity. After 72 h
of incubation, the culture medium was changed once every
3 days. At the third generation, cells were trypsinized, and
3 × 106 cells were plated in 100 mm culture dishes. The
cells were stimulated with 20 mg/L rhBMP-2 (Hangzhou
Jiuyuan Gene Engineering Co., Ltd., China) for one week,
and the medium was changed once every three days. The
morphology of the cells was observed everyday using an
inverted phase-contrast microscope (IX81; Olympus,
Japan). All protocols were approved by the Institutional
Animal Care and Use Committee (IACUC) at Southern
Medical University (Approval No. 120333, 114522).
Gomori alkaline phosphatase staining
Gomori alkaline phosphatase staining was performed
on cultured BMSCs as per the instructions of BCIP/NBT
chromogenic alkaline phosphatase staining kit (Beyotime,
China). After fixation, cells were washed with PBS three
times, the BCIP/NBT staining working solution was
added, and the cells were incubated at room temperaturefor 30 min. The BCIP/NBT staining working solution were
then removed, and the cells were washed twice with
distilled water to terminate the color reaction. The cells
were observed and photographed using an inverted
phase-contrast microscope (IX81; Olympus, Japan).
Two-dimensional (2D) gel electrophoresis
Dry cells (100 mg) were lysed by adding 400 μL of lysis
buffer (8 M urea, 4% CHAPS, 0.48% Tris base, 40 mM
DTT, and 10 mMphenylmethylsulfonyl fluoride). The
lysis mixture was incubated at room temperature for
60 min and centrifuged at 15,000 rpm for 60 min at 4°C.
After centrifugation, the supernatant was collected and
quantified with a 2D QUANT protein Assay Kit (GE, USA).
The supernatant containing 300 μg of total cellular protein
(about 20 μL) was mixed with the sample buffer (7 M urea,
2 M thiourea, 4% CHAPS, 65 mM DTT, 0.2% ampholytes,
and a small amount of bromophenol blue) to a final
volume of 450 μL. Two-dimensional gel electrophoresis
(2-DE) was performed mainly according to the method
described in a previous report [8] using a 24-cm pH4-7
linear DryStrip (GE, USA). After rehydration, is oelectric
focusing (highest current set at 50 μA/gel, 20°C) and
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed. After electrophoresis, mass
spectrometry-compatible silver staining was applied [9].
The gel was scanned using a UMAX Power Look 1100
transmission scanner to obtain images, and the images
were analyzed with PDQuest 7.1.0 software. The analysis
included the detection of protein spots, quantification,
background removal, and cross-gel analysis. After
comparison of the two gels, protein spots corresponding to
a difference in expression greater than 2.5 times were
selected for matrix-assisted laser desorption/ionization-
time-of flight (MALDI-TOF) mass spectrometry.
In-gel digestion and MALDI-TOF mass spectrometry
The protein spots were excised from gels into 1–2 mm2
blocks. After in-gel digestion, MALDI-TOF-TOF mass
spectrometry was carried out using an ABI4700 (Applied
Biosystems, USA) system. The obtained data were analyzed
with the PMF Mascot database (http://www.matrixscience.
com/). The parameters used were: species, mammal; trypsin
digestion (the number of maximum missed cleavages was
set to 1); carbamidomethylation of cysteine residues was set
as a fixed modification; and mass error, 100 ppm.
Real-time quantitative PCR
The RNA extracted from BMSCs (1 μg) was first
reverse-transcribed into cDNA (PrimeScript; Takara,
China). The cDNA was then used as the template for
real-time quantitative PCR analysis (Maxima SYBR
Green/ROX qPCR Master Mix; Thermo Scientific,
Pittsburgh, PA). The primers for quantifying the mRNA
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ferritin light and heavy chains, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), which served as
the internal control, are listed below (Table 1). The
average ΔΔCT of LASP1, ferritin light and heavy chains,
and GAPDH from samples analyzed in triplicate was
calculated [10,11].
Western blotting
BMSCs in the exponential growth phase were lysed with
radio-immunoprecipitation assay (RIPA) buffer. The
expression level of LASP1 and ferritin light and heavy
chains in BMSC lysates were analyzed by western blotting.
The protein concentration of cell lysates was examinedControlA
B
Figure 1 rhBMP-2-induced BMSC osteogenic differentiation. (A) Cell m
control and BMP-2, respectively). The magnification is 100X. (B) Alkaline ph
differentiation of BMSCs, without or with treatment with rhBMP-2. The imabefore resolving the total cellular protein (50 μg/lane)
using SDS-PAGE. The proteins were transferred onto
nitrocellulose membranes and the membranes were then
blocked using 5% skim non-fat milk in Tris-buffered
saline (TBS). The membranes were then incubated with
primary antibodies specific for LASP1 (ab117806; Abcam,
USA), ferritin light chain (ab69090; Abcam, USA), and
ferritin heavy chain (ab65080; Abcam, USA). The
membranes were washed three times in TBS containing
0.1% Tween 20 and then incubated with the appropriate
secondary antibodies. The protein-antibody complexes
were detected using a chemiluminescence reagent kit
(ECL; Pierce Bio, USA). The protein-specific bands were
analyzed by semi-quantitative densitometry.
Statistical analysis
The data obtained from real-time quantitative PCR
and the density of protein bands from western blotting
analysis were analyzed with SPSS12.0 software (SPSS Inc.,
Chicago, IL). The data shown are the mean ± SD. The
comparison of quantitative data was carried out using
independent sample t-test and a value of p < 0.05 was
considered to be statistically significant.
Results
rhBMP-induced osteogenesis in BMSCs
The BMSCs were cultured and treated with rhBMP-2 as
described in materials and methods. The cell morphology
was analyzed by observation under a microscope. TheBMP-2 7 d
orphology of BMSCs without or with rhBMP-2 induction (labeled as
osphatase staining was used to determine the status of osteogenic
ge magnification is 100X.
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shapes. At day 7 of culture, the number of cells increased,
the size of the cells enlarged, and the cells became
elongated (Figure 1A, control). During continued
culture, the cells remained long and spindle-shaped.
After induction with rhBMP-2, the shapes of the BMSCs
began changing gradually. Seven days after induction,
the cell morphology drastically changed from long
spindle-like cells to cubic cells (Figure 1A, BMP-2). The
osteogenesis potential of rhBMP-2-induced BMSCs was
evaluated by staining for alkaline phosphatase activity,
a marker for ostoeblastic differentiation. When BMSCs
were treated with rhBMP-2 for 7 days, a lot of dark blue
dots appeared, indicating the presence of alkaline
phosphatase activity (Figure 1B, BMP-2). In BMSCs that
had not been treated with rhBMP-2, only a few alkaline
phosphatase spots were detected (Figure 1B, control).
These results show that BMSCs from beagles can be
successfully cultured and that osteogenes can be induced






Figure 2 Proteomics analysis of protein expression profiles in rhBMP-
or with rhBMP-2 induction (labeled as control and BMP-2, respectively). (B
(A). Protein number 4, LASP1; Number 11 and 12, ferritin light and heavy cTwo-dimensional gel electrophoresis
The protein extracts from non-induced and rhBMP-2
induced BMSCs were examined by two-dimensional gel
electrophoresis followed by silver staining. The images
of the silver-stained gels were clear and without
background interference (Figure 2A, control and BMP-2).
The protein spots were completely separated and similar
results were obtained in all three independent trials
of the experiment. An average of 1125 protein spots
could be identified in the gel images from the three
independent trials. The matching protein spots in the
gels corresponding to the control (non-induced) and
rhBMP-2-treated samples were considered to originate
from the same proteins. The results showed that the
percentage of matched proteins from the two groups
of cells was approximately 90.84%.
After manual comparison and PDQuest 7.1.0 software
analysis of the protein spots, 20 proteins with significant
differences of expression levels between the control and
induced cells were selected for further analysis. The11
12
BMP -2 7 d
C
2-induced BMSCs. (A) 2D gel electrophoresis maps of BMSCs without
and C) Close-up images of cropped sections of 2-DE maps shown in
hains.









1 Eukaryotic translation initiation
factor 3 subunit K isoform 1




2 Heat shock protein beta-6 gi|57038366 100 17382.1 5.95 HFSPEEIAVK 21 <0.1
VVGDHVEVHAR
HEERPDEHGYIAR


















5 Glucose-6-phosphate isomerase gi|296080693 94 63147 8.42 VDHQTGPIVWG 7.5 <0.1
KTFTTQETIT
RSGDWKGYTGCETHAMLP YDQ










8 Poly(rC) binding protein 1 gi|222352151 95 37498 6.66 SSSPEVKGYWA 7 <0.1
NSSMTNSTAASRPP
9 Signal transducer and activator
of transcription 1
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Table 2 The proteins identified by proteomics analysis (Continued)









































14 Proteasome activator complex
subunit 3, isoform 6
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17 Solute carrier family 25
(mitochondrial carrier;
phosphate carrier), member 3
gi|119618005 87 40,095 9.45 SVVSVLNKE 10 4
DAAPKMYKEEGL
IFNGFSVTLKEDGVRG
18 ATP-binding cassette, sub-family B
(MDR/TAP), member 1
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down-regulated by 2 times or more, and proteins that
were either down-regulated (9 proteins) or up-regulated
(11 proteins) in the BMP-2-induced cells were analyzed
further by MALDI-TOF mass spectrometry for protein
identification (Table 2). The proteins numbered as 4, 11,and 12 in Table 2 were identified as LASP1 isoform 2,
ferritin light chain, and ferritin heavy chain (Figure 2B
and C, marked by red arrows). Mass spectrometry
peptide fingerprint peaks of these three proteins are
shown in Figure 3A-C, respectively. The expression of
the mRNAs corresponding to these three proteins in
AB
C
Figure 3 Peptide fingerprint map obtained using MALDI-TOF mass spectrometry. (A) LASP1. (B) Ferritin light chain. (C) Ferritin heavy chain.
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quantitative PCR. Compared with the expression levels in
the control cells, the expression of LASP1 decreased, whilethat of ferritin light and heavy chains increased, in the
rhBMP-2-induced cells (p < 0.05) (Figure 4A). The expres-
sion levels of these three proteins in the non-induced and
AB
Figure 4 Confirmation of RNA and protein expression levels by real-time quantitative PCR and western blotting analysis (n = 3, per
treatment type). (A) The expression of LASP1 and ferritin light and heavy chain mRNAs relative to that of GAPDH, the internal control, as
detected by real-time PCR. (B) Expression of LASP1 and ferritin light and heavy chains, as assessed by western blotting analysis. The signal corresponding
to the protein bands was quantified using densitometric scanning and the relative protein abundance was determined after normalization with the levels
of β-actin protein. Data are presented as mean ± SD and compared using the t-test for independent samples. *p <0.05, indicating significant differences
between the two samples compared.
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Consistent with the expression data for the mRNA, LASP1
protein levels were higher in control cells, while the levels
of ferritin light and heavy chains was higher in the BMP-2-
treated cells (Figure 4B). Densitometric analysis of protein
bands from the western blots also indicated the same pat-
tern of expression as that from the real-time quantitative
PCR analysis of mRNA expression (p < 0.05) (Figure 4B).
Discussion
In this study, beagle BMSCs were successfully isolated and
cultured. The BMSCs were stimulated with rhBMP-2 toinduce osteogenic differentiation. After 7 days of stimula-
tion, osteogenic differentiation of BMSCs was seen,
confirmed by the morphological changes in BMSCs and
the appearance of alkaline phosphatase activity, a marker
for osteoblastic differentiation. The protein expression
profiles of untreated control and rhBMP-2-treated BMSCs
were characterized using 2D gel electrophoresis. Compari-
son of the two protein expression profiles indicated that 9
proteins were up-regulated and 11 proteins were
down-regulated after stimulation of BMSCs with
rhBMP-2. Based on previously published reports and
bioinformatics analysis, two proteins, LASP1 and ferritin
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as candidate proteins involved in osteogenic differentiation
induced by BMP-2. The results from real-time quantitative
PCR and western blotting analyses confirmed the
down-regulation of LASP1 and the up-regulation of ferritin
in rhBMP-2-induced BMSCs.
LASP1 protein contains one LIM, one SH3, and two
actin domains, and was first discovered in 1996 as a protein
that is over-expressed in breast cancer [12]. Studies about
LASP1 have almost all concentrated on LASP1 expression
in tumors. LASP1 is involved in regulating cellular
functions associated with actin-cytoskeleton-associated
membrane rearrangements [13-15]. One study showed that
aberrant expression of LASP1 can affect the formation of
cartilage tissue [16]. To our knowledge, ours is the first
study demonstrating a decrease in LASP1 expression
during the process of rhBMP-2-induced osteogenic
differentiation.
Ferritin is an important molecule in iron homeostasis in
cells [17]. Iron overload can inhibit osteoblast differenti-
ation and induce ferritin expression. Iron-provoked inhib-
ition of osteoblast activity is mediated by ferritin and its
ferroxidase activity [18]. We found that the expression of
ferritin light and heavy chains was increased in BMSCs
after induction of differentiation by rhBMP-2. The
possible role for the up-regulation of ferritin might be
that when stem cells in bone marrow are stimulated
by rhBMP-2, over-expression of ferritin causes the enrich-
ment of iron, thereby inhibiting osteogenic differentiation.
However, the concentration of iron ions in the culture
medium is maintained at steady levels, hence osteogenic
differentiation is not inhibited under in vitro culture
conditions, even though ferritin expressed is increased
upon stimulation with rhBMP-2. The extent and exact
mechanism(s) through which the expression of LASP1
and ferritin are altered upon stimulation with BMP-2
need to be addressed in further mechanistic studies of
osteogenic differentiation of BMSCs.
In summary, rhBMP-2 induces osteogenic differentiation
of BMSCs, decreases LASP1 expression, and increases
ferritin expression. LASP1 is a key factor involved in the
regulation of the cytoskeleton and ferritin controls cellular
iron homeostasis, and the expression changes in these
proteins likely play an important role in the process of
rhBMP-2-induced osteogenic differentiation. The results of
this study provide additional information regarding
the role of changes in expression of specific proteins
in driving BMP-2-induced osteogenic differentiation
and indicate the need for further studies to elucidate the
specific mechanism(s) through which BMP-2 promotes
differentiation of BMSCs.Competing interests
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